Results show that targeting the underlying cause of Dravet syndrome with zorevunersen may improve outcomes for people ...
LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a ...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...
Veeva Systems Inc. , a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fourth quarter and fiscal year ended January 31, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results